These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5899093)

  • 1. [The significance of INH metabolism analysis for therapy. II].
    Mydlak G; Volkmann W
    Z Tuberk Erkr Thoraxorg; 1965 Nov; 124(1):44-8. PubMed ID: 5899093
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of the isoniazid inactivation in the therapy of pulmonary tuberculosis].
    Gol'dshteĭn VD; Ioffe RA; Ponomareva ES
    Probl Tuberk; 1970; 48(1):34-9. PubMed ID: 5425443
    [No Abstract]   [Full Text] [Related]  

  • 3. [Errors in testing the INH content in the organism].
    Vilenskaia RN
    Probl Tuberk; 1970; 48(11):77-80. PubMed ID: 5516520
    [No Abstract]   [Full Text] [Related]  

  • 4. [Percentage ratio of free- and acetyl-INH in the urine as a method of determination of the INH inactivation pattern].
    Rózniecki J
    Gruzlica; 1968 Oct; 36(10):971-3. PubMed ID: 5715459
    [No Abstract]   [Full Text] [Related]  

  • 5. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Cas Lek Cesk; 1984 Feb; 123(6):158-64. PubMed ID: 6697364
    [No Abstract]   [Full Text] [Related]  

  • 6. [Simultaneous determination of INH and ethionamide concentration in the lung].
    Eule H; Werner E
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):335-8. PubMed ID: 5897863
    [No Abstract]   [Full Text] [Related]  

  • 7. [The pharmacokinetics of isoniazid in children (author's transl)].
    Advenier C; Saint-Aubin A; Scheinmann P; Paupe J
    Rev Fr Mal Respir; 1981; 9(5):365-74. PubMed ID: 7323401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of simultaneous administration of 5-bromosalicylhydroxamic acid (T40) and INH on the concentration of free INH in urine of tubercular patients].
    Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):149-52. PubMed ID: 5899137
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolism of isoniazid in humans. Reflexions of a practical nature].
    Fantoli U
    Lotta Tuberc; 1966; 36(7):231-45. PubMed ID: 5235940
    [No Abstract]   [Full Text] [Related]  

  • 10. [INH-metabolism and development of resistance].
    Volkmann W; Mydlak G
    Beitr Klin Erforsch Tuberk Lungenkr; 1965 Nov; 131(2):89-95. PubMed ID: 5881728
    [No Abstract]   [Full Text] [Related]  

  • 11. [INH-H 3 diffusion in tubercular lesions. Histoautoradiographic study].
    Popescu I; Nicolae M
    Ftiziologia; 1971; 20(5):489-94. PubMed ID: 5153655
    [No Abstract]   [Full Text] [Related]  

  • 12. [The value of serum level determinations for INH].
    de Graaff JL
    Ned Tijdschr Geneeskd; 1967 Nov; 111(46):2105-7. PubMed ID: 6064782
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resorption and intensity of inactivation of isoniazid].
    Temmere VA
    Probl Tuberk; 1967; 45(11):83-9. PubMed ID: 5607267
    [No Abstract]   [Full Text] [Related]  

  • 14. [Level of active isoniazid in the serum of tuberculous children].
    Lupasco I; Algeorge G; Ghiu-Cimpeanu V
    Poumon Coeur; 1965; 21(9):1105-14. PubMed ID: 5294745
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the effect of INH metabolism on the therapy of pulmonary tuberculosis].
    IWAINSKY H; KAUFFMANN GW; SIEGEL D; GERISCHER C
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 122():324-32. PubMed ID: 14406169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isoniazid pharmacokinetics in the combined chemotherapy of tuberculosis].
    Sokolova GB; Vilenskaia RN; Ivleva AIa; Galenko NN; Ziia AV
    Probl Tuberk; 1981 Oct; (10):24-8. PubMed ID: 7312844
    [No Abstract]   [Full Text] [Related]  

  • 17. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isoniazid therapy and monitoring plasma levels].
    Lamedica G; Penco G; Spandonari MM; Jannuzzi C
    Pediatr Med Chir; 1984; 6(1):103-8. PubMed ID: 6335749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetics of isoniazid metabolism after intravenous administration].
    Stepanov VM
    Probl Tuberk; 1981 Aug; (8):66-9. PubMed ID: 7291181
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of INH (Isoniazid) inhalation in patients with endobronchial tuberculosis (EBTB)].
    Yokota S; Miki K
    Kekkaku; 1999 Dec; 74(12):873-7. PubMed ID: 10655693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.